Results

Total Results: 2,963 records

Showing results for "therapeutic".

  1. digital.ahrq.gov/sites/default/files/docs/publication/r18hs018665-storch-final-report-2015.pdf
    January 01, 2015 - the needs of each client and, depending on the design, could lack important therapeutic components. … A randomized controlled trial of computer-assisted cognitive-behavioral therapy versus treatment as … A randomized controlled trial of computer-assisted cognitive-behavioral therapy versus treatment as … A randomized controlled trial of computer-assisted cognitive-behavioral therapy versus treatment as … CCBT=Computer-assisted cognitive-behavioral therapy; TAU=treatment as usual; PARS=Pediatric Anxiety
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-staging_disposition-comments.pdf
    November 20, 2014 - TEP Reviewer 2 Introduction 2) page 31/231, Staging, line27-28 “...and may require neoadjuvant therapy … Peer Reviewer 4 Results Page 29, provide explicit definition of “correct treatment”, “under- treatment … ” and “over-treatment”. … Report points to intermediate outcomes and defines these as stage reclassification and changes in therapeutic … In recent years, innovative, dose-lowering technologies assessing whether therapeutic interventions
  3. Gout Executive-2016 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive-2016.pdf
    January 01, 2016 - arthritis can present with clinically similar signs and symptoms, but the conditions have different treatments … Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. … Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. … Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics … between gout flares, time in treatment, serum uric acid level and urate lowering therapy.
  4. www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication-january-2017
    January 10, 2017 - benefits of folic acid supplementation may vary by dosage, timing relative to pregnancy, duration of therapy … Eight fair-quality case-control studies addressed dose, timing, or duration of therapy. 1 Of these 8 … No evidence was found on harms differing by duration of therapy. 1 . … vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics
  5. digital.ahrq.gov/sites/default/files/docs/citation/k08hs018538-gesteland-final-report-2014.pdf
    January 01, 2014 - Consider the orientation of a typical ambulatory primary care clinician faced with making diagnostic and treatment … data about their individual practice patterns and recommendations about diagnosis, prevention, and treatment—provide … The best possible care includes cost effective diagnostic practices and therapeutic applications that … diagnosing acute respiratory infections (ARIs), discussing the diagnosis & management of ARI and describing treatment
  6. effectivehealthcare.ahrq.gov/sites/default/files/ch_1-user-guide-to-ocer_130129.pdf
    August 13, 2012 - If phase 2 studies show that the drug has a therapeutic effect and lacks significant adverse effects … For instance, under this staged approach new treatments could rapidly diffuse into a market even when … therapy will lead to the outcomes of interest and the likelihood that this conclusion will be affected … On the other hand, a patient who has a health condition where there are few treatments may be willing … This panel portrays health care treatments as providing a large zone of 15 Chapter 1.
  7. www.uspreventiveservicestaskforce.org/home/getfilebytoken/BXkaHRFGjwUCoyANeMSuTz
    January 01, 2010 - Treatment for hypertension has traditionally been defined as pharmacological or nonpharmacological therapy … Pharmacological Treatments for Adults with Hypertension Stage 3 Hypertension. … Nonpharmacological Therapies in Adults RCTs of nonpharmacological therapies have examined CVD events … Additionally, treatment of adult hypertensive patients with drug therapy and possibly nonpharmacological … New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit.
  8. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/high-blood-pressure-adults-children-adolescents-screening-2003
    April 01, 2003 - Treatment for hypertension has traditionally been defined as pharmacological or nonpharmacological therapy … Pharmacological Treatments for Adults with Hypertension Stage 3 Hypertension. … Nonpharmacological Therapies in Adults RCTs of nonpharmacological therapies have examined CVD events … Additionally, treatment of adult hypertensive patients with drug therapy and possibly nonpharmacological … New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit.
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-221-copd-evidence-summary_0.pdf
    October 01, 2019 - on evidence from randomized controlled trials (RCTs) as the gold standard design for evaluating a therapeutic … Pharmacologic Therapies Versus Placebo or Management Without Pharmacologic Therapies The evidence … and individual treatments. … The response to antibiotic therapy as well as corticosteroid therapy in ECOPD likely differs based … therapy versus placebo in ECOPD,48 but identification of responders to systemic corticosteroid treatment
  10. www.ahrq.gov/sites/default/files/2024-12/doucette-report.pdf
    January 01, 2024 - We evaluated interventions for MTM by randomizing pharmacies and patients into two treatment groups … Both treatment groups received automated targeted interventions and a patient engagement intervention … One treatment group also received pharmacist training. … intended to improve drug therapy for Medicare beneficiaries. … Clinical Therapeutics. 2013 Mar; 35(3):344-350.
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-disease-medicine_research-protocol.pdf
    November 01, 2010 - Third, CKD may be a marker for individuals less likely to receive proven medical therapies. … individuals with a myocardial infarction, those with CKD are less likely to receive proven effective therapies … associated underlying conditions or cardiovascular risk factors, such as hypertension or diabetes,21 with therapeuticTreatments may be CKD- specific or non-specific. … treatments and kidney disease.
  12. www.ahrq.gov/research/findings/final-reports/crctoolkit/crctoolkit3.html
    April 01, 2018 - that patients understand that this is a focus group for an intervention and not part of a support or therapeutic
  13. effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … Adherence to long-term therapies. … Wirelessly observed therapy in comparison to directly observed therapy for the treatment of tuberculosis
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-214-afib-disposition-comments.pdf
    October 30, 2019 - predicting stroke and bleeding risk in persons with AFib, and comparative effectiveness of a variety of therapies … The “as treated” (treatment received) analysis compares the actually received treatments. … do not seem like clear labels, since both are active treatments. … We have separated the tables out as to whether the patients are on therapy or not, the specific therapies … We have expanded this section to include information on the various treatments.
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prosthesis_research-protocol.pdf
    March 16, 2017 - eligible for a defined Medicare benefit category, 2) be reasonable and necessary for the diagnosis or treatment … community ambulator who has the ability to traverse most environmental barriers and may have vocational, therapeutic … vascular dysfunction, skin ulceration/damage, visual dysfunction, peripheral neuropathy, local cancer treatment … of amputation o Time since amputation o Comorbidities (e.g., diabetes, CVD, PVD) o Operative treatment … “Preservation-Amputation Care and Treatment (PACT) Program.” In: Affairs DoV, editor.
  16. effectivehealthcare.ahrq.gov/sites/default/files/back-pain-treatment_research_executive.pdf
    February 01, 2016 - Comparisons were of an included therapy versus placebo (drug trials), sham treatments (nonpharmacological … Nonpharmacological treatments versus sham, no treatment, or usual care for acute or subacute low back … , which could attenuate treatment benefits if suboptimal treatment techniques or intensity of therapy … In addition, a number of nonpharmacological therapies (e.g., psychological therapies, exercise therapyTherapeutic aquatic exercise in the treatment of low back pain: a systematic review.
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
    March 01, 2010 - Because of concern that some patients might receive H-ISDN late in their illness as a salvage treatment … for very severe HF that had proven refractory to other treatments. … A comparison of enalapril with hydralazine- isosorbide dinitrate in the treatment of chronic congestive … A review of uses of health care utilization databases for epidemiologic research on therapeutics. … Mortality hazard ratios for receipt of selected heart failure therapies or combinations versus no therapy
  18. www.ahrq.gov/sites/default/files/2024-02/zierler-report.pdf
    January 01, 2024 - The clinical tools include treatment and prevention guidelines, provider order sets, risk assessment … and who were discharged with appropriate outpatient therapy. 5. … The VTE Safety Toolkit consists of diagnostic, preventive, and therapeutic algorithms as well as a mandatory … Improve the treatment of VTE once it occurs, both in hospital and after discharge. … for VTE, and patient education for VTE prevention and treatment.
  19. effectivehealthcare.ahrq.gov/sites/default/files/ch_4-user-guide-to-ocer_130129.pdf
    January 01, 2010 - are the timeframe (induction and latent periods), changes in exposure status or exposure to other therapies … Similarly, in a comparative evaluation of cognitive behavioral therapy (CBT) for treatment of depression … questions for the same chronic condition may use different approaches to measuring exposure to the treatments … When using data outside of the United States, the World Health Organization’s Anatomical Therapeutic … Exposure to Multiple Therapies A complexity in observational CER is the lack of control over other
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_executive.pdf
    April 28, 2010 - (e.g., referred for specialty treatment). … Treatments for alcohol dependence • Cognitive behavioral therapy • Motivational enhancement therapy … It is possible that the assessments of alcohol misuse conducted in the included trials conceal therapeutic … RCT of effectiveness of motivational enhancement therapy delivered by nurses for hazardous drinkers … Assessment may conceal therapeutic benefit: findings from a randomized controlled trial for hazardous